Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. AWK
10. ACN

Go back to Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress

Arcturus Therapeutics (ARCT) Tops Q2 EPS by 7c

August 9, 2021 4:28 PM EDT

Arcturus Therapeutics (NASDAQ: ARCT) reported Q2 EPS of ($2.07), $0.07 better than the analyst estimate of ($2.14). Revenue for the quarter came in at $2 million versus the consensus estimate of $2.32 million.

ARCT-021, Arcturus single shot STARR mRNA COVID vaccine, to begin multinational placebo-controlled Phase 3 efficacy study... More